Adial Pharmaceuticals, Inc.
ADIL· Nasdaq
ADILAdial Pharmaceuticals, Inc.
Filed Mar 4, 2025 · 10-K · 63 days after period end · 0001213900-25-019771
derived · Computed from the longer spans the company filed.
| Metric | Q4 2024dderived from reported figures | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures | Q4 2021dderived from reported figures |
|---|---|---|---|---|
| Net Income | -$2.07M | -$1.92M | -$2.87M | -$5.83M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Adial Pharmaceuticals, Inc. · CIK 1513525 · Engraved from SEC EDGAR
ended Dec 31, 2024 · filed Mar 4, 2025 · 63 d after period end
